Results 131 to 140 of about 91,638 (253)

Virulence determinants and toxin profile of methicillin resistant Staphylococcus aureus from commercial cheese in Bangladesh: A public health risk. [PDF]

open access: yesPLoS One
Hossain MT   +10 more
europepmc   +1 more source

Chronic Expanding Hematoma Complicated by Life Threatening Hemoptysis and Respiratory Arrest—A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 7, July 2026.
In this report, we describe a patient with the rare diagnosis of chronic expanding hematoma, leading to life‐threatening hemoptysis and ultimately type 2 respiratory failure. This case highlights the importance of proactive management for CEH due to its potentially fatal complications.
Anthony Shing‐yiu Yu   +7 more
wiley   +1 more source

Pathoadaptive evolution and clonal dissemination of community- associated methicillin-resistant Staphylococcus aureus in Egypt. [PDF]

open access: yesBMC Infect Dis
Saif NA   +7 more
europepmc   +1 more source

Establishing the Epidemiological Cut‐Off Value (ECOFF) for Cefquinome Against Staphylococcus aureus Using Standardised MIC Data

open access: yesVeterinary Medicine and Science, Volume 12, Issue 4, July 2026.
A total of 110 Staphylococcus aureus isolates from cattle were analysed to determine the epidemiological cut‐off value (ECOFF) for cefquinome. Minimum inhibitory concentrations (MICs) were determined using standardised agar dilution and broth microdilution methods following 24 h incubation.
Ijaz Ahmad   +8 more
wiley   +1 more source

Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A

open access: yesAngewandte Chemie, Volume 138, Issue 26, 22 June 2026.
Genetic de‐regulation of a silent biosynthetic pathway allowed isolation and characterisation of a novel glycopeptide antibiotic named biffamycin A, which harbours unprecedented 5‐chloro‐4‐methoxy tryptophan and 3R‐hydroxy(α‐D‐mannoysl)‐D‐lysine moieties and is bioactive against MRSA and VRSA.
Michael W. Brigham   +11 more
wiley   +2 more sources

Panton-Valentine Leukocidin-Encoding Methicillin-Resistant Staphylococcus aureus, the Netherlands, 2023-2024<sup>1</sup>. [PDF]

open access: yesEmerg Infect Dis
van Schelven P   +11 more
europepmc   +1 more source

Efficacy of Vitex pseudo‐negundo in a Bovine Mastitis Model Experimentally Induced by Staphylococcus aureus in Rats

open access: yesVeterinary Medicine and Science, Volume 12, Issue 4, July 2026.
This study evaluated the therapeutic efficacy of Vitex pseudo‐negundo (VPN) extracts in a Staphylococcus aureus‐induced mastitis rat model. Following extraction with water, methanol and petroleum ether, in vitro MICs were determined. Rats established with mastitis received 5‐day treatments.
Hüseyin Koç   +5 more
wiley   +1 more source

Optimising Therapeutic Target Attainment in Vancomycin Therapy for Patients Requiring Intermittent Haemodialysis

open access: yesNephrology, Volume 31, Issue 7, July 2026.
Optimal vancomycin dosing in dialysis patients. ABSTRACT Aims To describe the pharmacokinetics of vancomycin in patients requiring intermittent haemodialysis (iHD) and provide guidance for optimised dosing for a three‐times‐weekly post‐iHD regimen. Methods A population pharmacokinetic study using retrospectively collected data was conducted in a remote
Danny Tsai   +10 more
wiley   +1 more source

Antibiotics in Veterinary Ophthalmology: Resistance, Stewardship, and Emerging Antibiotic‐Sparing Strategies

open access: yesVeterinary Ophthalmology, Volume 29, Issue 4, July 2026.
ABSTRACT Antimicrobial resistance (AMR) is a growing challenge in veterinary ophthalmology, particularly in cases of bacterial keratitis, where progressive stromal infection can threaten vision and globe integrity within hours to days. This review synthesizes current evidence on pathogen distribution, antimicrobial susceptibility profiles, multidrug ...
Lionel Sebbag, Oren Pe'er
wiley   +1 more source

Home - About - Disclaimer - Privacy